CONCLUSIONS: These results show that particularly open-label counterconditioning is an effective method to modulate nocebo effects on pressure pain. This provides promise in designing non-deceptive learning-based treatments to reduce nocebo effects in diverse patient groups, including chronic pain disorders. →

CONCLUSIONS: The findings of this study indicate that both surgical procedures may effectively treat Miller’s class I and II GRs, resulting in satisfactory root coverage. →

Central venous catheters (CVCs) are used in hemodialysis patients when arteriovenous fistulas (AVFs) or grafts (AVGs) are not feasible. Catheter-locking anticoagulants (CLAs), such as low-concentration trisodium citrate (TSC) and unfractionated heparin (UFH), are used to prevent catheter dysfunction (CD), but comparative data on their safety and efficacy — especially at low concentration remain limited. This… →

Is 36 months too long for a new-product cycle? It was for Kraft Heinz. So, starting with a pilot project, it was able to cut time to market to just six months by redesigning how people worked. Today, units throughout the company are applying that model’s step-by-step approach to change and are seeing measurable improvements… →
CONCLUSIONS: This computer-based study suggests that Visual Patient Wearable visualizations enhance patients’ ability to detect and recall simulated vital sign deviations. Participants found the system intuitive, easy to learn, and reassuring. The Visual Patient Wearable system provides an at-a-glance interface that may support patients’ understanding of their vital signs and could facilitate communication of relevant… →

CONCLUSION: The posterolateral mini-incision approach for HHA in elderly patients with hip fractures can optimize surgical outcomes, reduce postoperative pain and complications, improve hip joint function, and promote better postoperative recovery, resulting in overall superior effects. →

CONCLUSION: Ezetimibe added to high-intensity statin therapy was well tolerated and resulted in an immediate and robust additional decrease in circulating LDL-C concentrations, with a markedly higher proportion of participants achieving LDL-C goals at 4 and 12 weeks. These promising results show that dual therapy started immediately at the diagnosis of ACS has the potential… →

CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, mTBI symptoms and patients’ perception of change improved similarly for the T-MD and control groups. These findings can inform a more effective, efficient, and evidence-based approach to care for mTBI. →

CONCLUSIONS: Enhancing mindfulness and compassionate processes in peer-counselor training serve a central role in improving anxiety and functional quality of life, thereby alleviating depressive symptoms in breast cancer survivors. →

CONCLUSION: Lebrikizumab demonstrated off-therapy maintenance of response in an AD patient subset for at least 38 weeks post-discontinuation. →
